MLYS - Latest News
Mineralys Therapeutics, Inc. (MLYS), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $1.77B. Beta to the broader market is 0.56.
The article list below shows the most recent MLYS headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent MLYS Headlines
What a $350,000 Insider Sale Might Mean for Mineralys Ahead of December FDA Decision
fool.com - Jun 23, 2026
This clinical-stage biotech focused on hypertension therapies reported a notable insider sale amid strong one-year stock performance.
Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
globenewswire.com - Jun 14, 2026
– Lorundrostat was associated with significant reductions in heart failure risk biomarkers in a proteomic analysis of data from participants with unco
Mineralys Therapeutics, Inc. (MLYS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
seekingalpha.com - Jun 11, 2026
Mineralys Therapeutics, Inc.
Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
globenewswire.com - Jun 8, 2026
RADNOR, Pa. , June 08, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc.
Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
globenewswire.com - Jun 8, 2026
RADNOR, Pa. , June 08, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc.
How News Affects MLYS Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MLYS's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked MLYS news questions
- What is the latest MLYS news headline?
- The most recent MLYS headline (Jun 23, 2026) is "What a $350,000 Insider Sale Might Mean for Mineralys Ahead of December FDA Decision". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the MLYS news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What MLYS news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual MLYS options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.